Genomics is having a moment. As sequencing costs keep falling and clinical adoption keeps rising, next generation sequencing (NGS) has moved from a research-lab novelty to a cornerstone of modern diagnostics and drug development. Here's a look at where the market stands today, who's leading it, and what's driving its next phase of growth. Market Snapshot The global next generation sequencing...